131 related articles for article (PubMed ID: 15652904)
1. Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model.
Efstathiou JA; Sampson DA; Levine Z; Rohan RM; Zurakowski D; Folkman J; D'Amato RJ; Rupnick MA
Fertil Steril; 2005 Jan; 83(1):171-81. PubMed ID: 15652904
[TBL] [Abstract][Full Text] [Related]
2. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model.
Becker CM; Sampson DA; Short SM; Javaherian K; Folkman J; D'Amato RJ
Fertil Steril; 2006 Jan; 85(1):71-7. PubMed ID: 16412733
[TBL] [Abstract][Full Text] [Related]
3. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
Becker MC; Wang TH; Wisniewski L; Wolski K; Libby P; Lüscher TF; Borer JS; Mascette AM; Husni ME; Solomon DH; Graham DY; Yeomans ND; Krum H; Ruschitzka F; Lincoff AM; Nissen SE;
Am Heart J; 2009 Apr; 157(4):606-12. PubMed ID: 19332185
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis.
Olivares C; Ricci A; Bilotas M; Barañao RI; Meresman G
Fertil Steril; 2011 Aug; 96(2):428-33. PubMed ID: 21683949
[TBL] [Abstract][Full Text] [Related]
5. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
[TBL] [Abstract][Full Text] [Related]
7. Suppression of accelerated tumor growth in surgical wounds by celecoxib and indomethacin.
Roh JL; Sung MW; Kim KH
Head Neck; 2005 Apr; 27(4):326-32. PubMed ID: 15719392
[TBL] [Abstract][Full Text] [Related]
8. Regression of endometrial explants in a rat model of endometriosis treated with melatonin.
Güney M; Oral B; Karahan N; Mungan T
Fertil Steril; 2008 Apr; 89(4):934-42. PubMed ID: 17582405
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with celecoxib and rofecoxib utilization.
Rawson NS; Nourjah P; Grosser SC; Graham DJ
Ann Pharmacother; 2005 Apr; 39(4):597-602. PubMed ID: 15755796
[TBL] [Abstract][Full Text] [Related]
10. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model.
Machado DE; Berardo PT; Landgraf RG; Fernandes PD; Palmero C; Alves LM; Abrao MS; Nasciutti LE
Fertil Steril; 2010 May; 93(8):2674-9. PubMed ID: 20056215
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing.
Cohen DB; Kawamura S; Ehteshami JR; Rodeo SA
Am J Sports Med; 2006 Mar; 34(3):362-9. PubMed ID: 16210573
[TBL] [Abstract][Full Text] [Related]
12. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
[TBL] [Abstract][Full Text] [Related]
13. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis.
Hull ML; Prentice A; Wang DY; Butt RP; Phillips SC; Smith SK; Charnock-Jones DS
Hum Reprod; 2005 Feb; 20(2):350-8. PubMed ID: 15567877
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
Chen JT; Pucino F; Resman-Targoff BH
J Pain Palliat Care Pharmacother; 2006; 20(4):11-32. PubMed ID: 17182503
[TBL] [Abstract][Full Text] [Related]
15. Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: a class effect?
Hudson M; Rahme E; Richard H; Pilote L
Arthritis Rheum; 2007 Apr; 57(3):516-23. PubMed ID: 17394181
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
Rudzitis-Auth J; Menger MD; Laschke MW
Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human endostatin on endometriosis in mice.
Jiang HQ; Li YL; Zou J
Chin Med J (Engl); 2007 Jul; 120(14):1241-6. PubMed ID: 17697575
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
[TBL] [Abstract][Full Text] [Related]
20. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib.
Dogan E; Saygili U; Posaci C; Tuna B; Caliskan S; Altunyurt S; Saatli B
Fertil Steril; 2004 Oct; 82 Suppl 3():1115-20. PubMed ID: 15474083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
